Journal of evidence-based medicine

Stopping Diabetes Drugs That Activate GLP-1 Receptors After Bowel Blockage or Intestinal Paralysis: A Large Real-World Study

Updated

Abstract

The frequency of glucagon-like peptide-1 receptor agonist (GLP-1RA) discontinuation after hospitalization for bowel obstruction or ileus is examined.

  • Concerns exist that GLP-1RAs may be linked to increased risks of bowel obstruction or ileus.
  • Evidence regarding the relationship between GLP-1RAs and bowel obstruction/ileus remains inconclusive.
  • The study investigates the reasons behind the discontinuation of GLP-1RAs following hospitalization for these conditions.
  • Determinants of GLP-1RA discontinuation are explored in the context of recent hospitalizations.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free